A randomized controlled trial (Click here to access the source) has found excellent pain relief and no clinical difference among spinal cord stimulation frequencies from 1kHz to 10kHz, including 1kHz, 4kHz, 7Khz, and 10Khz.
Since 1kHz stimulation provides similar pain relief using significantly less energy than higher frequencies, devices with higher battery-charge longevity are possible and should be better alternatives to the 10kHz HF10 therapy.
A recent study suggests that executive functions can be rapidly up- or down-regulated by modulating theta phase coupling of distant frontal cortical areas and can contribute to the development of tools for potentially normalizing executive dysfunction in patient populations.
About 75 percent of people with MS (Multiple Sclerosis) report fatigue among their most disabling disease symptoms.
Medications, such as those that treat narcolepsy, behavior-based therapies and even exercise programs are often prescribed but benefits have been found to be unreliable.
When compared to patients who were enrolled in a placebo arm of a recent study those that received transcranial direct current stimulation (tDCS) were found to have about a six-point drop on a 32-point scale measuring fatigue severity, according to the findings recently published online in the Multiple Sclerosis Journal.
The exact mechanism behind tDCS is unclear and requires more research. It is thought to change the brain's cortical excitability by making it easier for neurons to fire, thereby improving connections and expediting learning that takes place during rehabilitation.